Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team, Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023. PMID: 36650479

Year

2023

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1078

Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia

International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team, Jean Rene Anderson, Deborah Kacanek, Yanling Huo, Kevin Psoter, Lisa R Yanek, Khalil Ghanem, Irina Burd, Anna Maya Powell, Deborah Persaud. Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. 2023. PMID: 36680487

Year

2023

Journal

American Journal of Reproductive Immunology

Study

P1025

HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant

Lawrence D Petz, Marshall J. Glesby, Renee Browning, Savita Pahwa, Deborah Persaud, Anne Coletti, Yvonne Bryson, Meredith G. Warshaw, IMPAACT P1107 Team, Theodore B. Moore, Ya Hui Chen, Suresh Pallikkuth, Adit Dhummakupt, Ruth Cortado, Amanda Golner, Frederic Bone, Maria Baldo, Marcie Riches, Jingmei Hsu, John W. Mellors, Koen Van Besien, Nicole H. Tobin. HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant. Cell. 2023. 186: 1115-1126.

Year

2023

Journal

Cell

Study

P1107

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial

Tapiwa Mbengeranwa, IMPAACT P1078 TB APPRISE Study Team, Gaerolwe Masheto, Patrick Jean-Phillippe, Nahida Chakhtoura, Gerhard Theron, Adriana Weinberg, Haseena Cassim, Mpho S Raesi, Elsie Jean, Ashenafi S Cherkos, Deo Wabwire, Sylvia M LaCourse, Teacler Nematadzira, Daniel A Enquobahrie, Lynda Stranix-Chibanda, Barbra A Richardson, Anneke C Hesseling, Sarah Bradford, Linda Aurpibul, Grace Montepiedra, Amita Gupta, Blandina T Mmbaga, Grace John-Stewart. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial. eClinicalMedicine. 2023. 58: 101912. PMID: 36969345

Year

2023

Journal

eClinicalMedicine

Study

P1078

Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study

Sean S. Brummel, Patricia DeMarrais, Rachel Chamanga, Maxensia Owor, Sufia Dadabhai, Joan T. Price, Taha Taha, Jeffrey Stringer, Mary Glenn Fowler, Benjamin H. Chi, Dorothy Sebikari. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study. PLoS One. 2023. 18: e0280730. PMID: 36689442

Year

2023

Journal

PLoS One

Study

1077BF, 1077FF

The cascade of care for household contacts of people with drug-resistant TB

Gavin Churchyard, Amita Gupta, Anneke C Hesseling, Susan Swindells, Wilfred Gurupira, Bruno Martel, Lungile Mbata, Sandesh Patil, Cynthia Riviere, Mariecef Tonquin, David Dowdy, Hojoon Sohn, Isabella Gomes, Tushar Garg. The cascade of care for household contacts of people with drug-resistant TB. International Journal of Tuberculosis and Lung Disease. 2023. 27: 154-156. PMID: 36853100

Year

2023

Journal

International Journal of Tuberculosis and Lung Disease

Study

IMPAACT 2003/ACTG 5300

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

Xingye Wu, Rosie Mngqbisa, Michael D Hughes, Rodrigo Otávio da Silva Escada, N Sarita Shah, Samuel Ouma, Sanjay Gaikwad, Barbara Heckman, Nishi Kumarasamy, Linda Naini, Erika Mitchell, Amita Gupta, Mey Leon, Susan Swindells, Pedro Gonzales, Gavin Churchyard, Sharlaa Badal-Faesen, ACTG A5300/IMPAACT 2003 PHOENIx Feasibility Study Team, Madeleine Lourens, Sandy Nerette, Justin Shenje, Petra de Koker, Supalert Nedsuwan, Soyeon Kim, Lerato Mohapi, Anneke C Hesseling, Unoda A Chakalisa. Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. PLoS One. 2023. 18: e0283290. PMID: 36930628

Year

2023

Journal

PLoS One

Study

IMPAACT 2003/ACTG 5300

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Kevin Knowles, Roger Shapiro, Sikhulile Moyo, Blandina Theophil Mmbaga, Lynda Stranix-Chibanda, Faeezah Patel, Risa Hoffman, Jean van Wyk, Paul E Sax, James F Rooney, Jeffrey Stringer, Judith S Currier, Nahida Chakhtoura, Shahin Lockman, Patrick Jean-Philippe, IMPAACT 2010/VESTED Study Team and Investigators, Violet Korutaro, Lameck Chinula, Haseena Cassim, Lauren Ziemba, Lee Fairlie, Sean Brummel, Gaerolwe Masheto, Katie McCarthy, Ceejay Boyce, Anne Coletti, Lisa M Frenkel, Chelsea Krotje, K Rivet Amico, Benjamin Johnston, Lynette Purdue. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023. S2352-3018: 00061-9. PMID: 37167996

Year

2023

Journal

Lancet HIV

Study

IMPAACT 2010

A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children

Dwight E. Yin, Stephen R. Cole, Christina Ludema, M. Alan Brookhart, Carol E. Golin, William C. Miller, Ross E. McKinney. A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children. American Journal Of Epidemiology. 2023. 192: 916-928. PMID: 36896583

Year

2023

Journal

American Journal Of Epidemiology

Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study

Haseena Cassim, Kevin Ryan, Jaime G. Deville, Hardik Chandasana, Ponego L. Ponatshego, Cynthia H. Brothers, Faeezah Patel, Ann M. Buchanan, Linda Aurpibul, Helena Rabie, Shaun L. Barnabas, Patricia M. Flynn, Iris Mustich, IMPAACT 2019 Study Team, Anne Coletti, Barbara Heckman, Kristina M. Brooks, Chelsea Krotje, Jennifer J. Kiser, Mark Lojacono, Lauren Ziemba, Dwight E. Yin, Shawn Ward, Ellen Townley, Yasha Rani, Jack Moye, Tim R. Cressey, Sai Majji, Gaerolwe R. Masheto, Edward P. Acosta. Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023. 10: E506-E517. PMID: 37541705

Year

2023

Journal

Lancet HIV

Study

IMPAACT 2019